SCHEMBL743494

SCHEMBL743494

CCCC[C](C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18613979 0.91 CES2 (0.46)
SCHEMBL1176708 0.88 CES2 (0.48)
SCHEMBL28315654 0.88 CES2 (0.48)
SCHEMBL18614056 0.88 CES2 (0.48)
SCHEMBL198724 0.84
SCHEMBL11126902 0.77 CES1 (0.40)
SCHEMBL16194365 0.77
SCHEMBL4633356 0.77 CES1 (0.40)
SCHEMBL7955527 0.75 CES1 (0.43)
SCHEMBL5967506 0.75 CES1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2920225-B1 REACTION ACCELERATOR FOR A COPOLYMERISATION , ELECTRICAL-INSULATION TAPE, ELECTRICAL-INSULATION BODY, AND CONSOLIDATION BODY SIEMENS AG (DE) 2017-11-29 EP claimed
US-20150361103-A1 REACTION ACCELERATOR FOR A COPOLYMERISATION, ELECTRICAL-INSULATION TAPE, ELECTRICAL-INSULATION BODY, AND CONSOLIDATION BODY SIEMENS AKTIENGESELLSCHAFT (DE) 2015-12-17 US claimed
EP-2762512-A1 Reaction accelerator for a copolymerization, electrical insulation tape, electrical insulation body and consolidation body Siemens Aktiengesellschaft (DE) 2014-08-06 EP claimed
US-20220151992-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF TENACIA BIOTECHNOLOGY (HONG KONG) CO., LIMITED (HK) 2022-05-19 US disclosed
US-11077094-B2 Spiro-lactam NMDA receptor modulators and uses thereof APTINYX INC. (US) 2021-08-03 US disclosed
US-20200206189-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF TENACIA BIOTECHNOLOGY (HONG KONG) CO., LIMITED (HK) 2020-07-02 US disclosed
US-10441571-B2 Spiro-lactam NMDA receptor modulators and uses thereof APTINYX INC. (US) 2019-10-15 US disclosed
US-10383877-B2 Use of substituted 2, 3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma BAYER INTELLECTUAL PROPERTY GMBH (DE) 2019-08-20 US disclosed
CN-109111536-A Catalytic component and its catalyst for olefinic polymerization 中国石油化工股份有限公司 2019-01-01 CN disclosed
CN-109111539-A Catalytic component and its catalyst for olefinic polymerization 中国石油化工股份有限公司 2019-01-01 CN disclosed
US-10087198-B2 Reaction accelerator for a copolymerisation, electrical-insulation tape, electrical-insulation body, and consolidation body SIEMENS AKTIENGESELLSCHAFT (DE) 2018-10-02 US disclosed
US-20080286832-A1 Methods for Obtaining Optically Active Epoxides and Vicinal Diols From 2,2-Disubstituted Epoxides COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH (ZA) 2008-11-20 US disclosed
US-20080213833-A1 Methods for Obtaining Optically Active Glycidyl Ethers and Optically Active Vicinal Diols from Racemic Substrates OXRANE (UK) LTD. (GB) 2008-09-04 US disclosed
US-20080199912-A1 Methods for Obtaining Optically Active Epoxides and Diols from 2,3-Disubstituted and 2,3-Trisubstituted Epoxides OXYRANE (UK) LTD. (GB) 2008-08-21 US disclosed
EP-1885849-A2 METHODS FOR OBTAINING OPTICALLY ACTIVE GLYCIDYL ETHERS AND OPTICALLY ACTIVE VICINAL DIOLS FROM RACEMIC SUBSTRATES Oxyrane UK Limited (GB) 2008-02-13 EP disclosed
US-20070275448-A1 Methods For Obtaining Optically Active Epoxides And Vicinal Diols From Meso-Epoxides CSIR (ZA) 2007-11-29 US disclosed
EP-1753862-A2 METHODS FOR OBTAINING OPTICALLY ACTIVE EPOXIDES AND VICINAL DIOLS FROM MESO-EPOXIDES CSIR (ZA) 2007-02-21 EP disclosed
WO-2006109198-A2 METHODS FOR OBTAINING OPTICALLY ACTIVE GLYCIDYL ETHERS AND OPTICALLY ACTIVE VICINAL DIOLS FROM RACEMIC SUBSTRATES OXYRANE UK LIMITED (GB) 2006-10-19 WO disclosed
WO-2005100578-A2 METHODS FOR OBTAINING OPTICALLY ACTIVE EPOXIDES AND VICINAL DIOLS FROM MESO-EPOXIDES CSIR (ZA) 2005-10-27 WO disclosed
EP-0005504-A1 Process for the preparation of 5,5-disubstituted-4-ureido-hexahydropyrimidines BASF Aktiengesellschaft (DE) 1979-11-28 EP disclosed